Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

J. Barker, M. Hoffmann, G. Wozel, J. -P. Ortonne, H. Zheng, H. van Hoogstraten, K. Reich*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

179 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)'. Together they form a unique fingerprint.

Medicine and Dentistry